ロード中...
Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures
Modeling and simulations were used to support body weight-based dose selection for eslicarbazepine acetate (ESL) in pediatric subjects aged 4–17 years with partial-onset seizures. A one-compartment pediatric population pharmacokinetic model with formulation-specific first-order absorption, first-ord...
保存先:
| 出版年: | J Pharmacokinet Pharmacodyn |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6061080/ https://ncbi.nlm.nih.gov/pubmed/29948795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10928-018-9596-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|